Abbott Laboratories (NYSE: ABT) reported Q4 EPS of $1.03, $0.04 better than the analyst estimate of $0.99. Revenue for the quarter came in at $9.46 billion versus the consensus estimate of $9.35 billion.

Abbott Laboratories sees FY2012 EPS of $5.00-$5.10, versus prior guidance of $4.95-$5.05 and the consensus of $5.01.

For earnings history and earnings-related data on Abbott Laboratories (ABT) click here.

Earnings Guidance Hot Earnings Hot Guidance